Omega-3 fatty acids and atrial fibrillation

Korean J Intern Med. 2023 May;38(3):282-289. doi: 10.3904/kjim.2022.266. Epub 2022 Dec 14.

Abstract

Although some clinical trials have demonstrated reduced incidence of cardiovascular disease with the use of omega-3 fatty acids, others have found an increased risk of atrial fibrillation (AF). AF is the most common sustained cardiac arrhythmia worldwide. It is associated with high morbidity and mortality rates and significant public health burden. Previous studies of the effect of omega-3 fatty acids on AF occurrence have reported contradictory results. Here we reviewed the effect of omega-3 fatty acids on the risk of AF.

Keywords: Atrial fibrillation; Cardiovascular diseases; Clinical trials; Fatty acids, omega-3; Triglycerides.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Fatty Acids, Omega-3* / therapeutic use
  • Humans
  • Incidence

Substances

  • Fatty Acids, Omega-3